Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
CSL112 (Apolipoprotein A-I [Human]) Strongly Enhances Plasma Apoa-I and Cholesterol Efflux Capacity in Post-Acute Myocardial Infarction Patients: A PK/PD Substudy of the AEGIS-I Trial.
Journal: Journal of cardiovascular pharmacology and therapeutics
Published: October 25, 2022
Biological basis and proposed mechanism of action of CSL112 (apolipoprotein A-I [human]) for prevention of major adverse cardiovascular events in patients with myocardial infarction.
Journal: European heart journal. Cardiovascular pharmacotherapy
Published: December 09, 2021
Cholesterol Efflux Capacity and Its Association With Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis.
Journal: Frontiers in cardiovascular medicine
Published: September 11, 2021
Effect of azithromycin and hydroxychloroquine in patients hospitalized with COVID-19: Network meta-analysis of randomized controlled trials.
Journal: Journal of medical virology
Published: June 28, 2021
The AngelMed Guardian® System in the Detection of Coronary Artery Occlusion: Current Perspectives.
Journal: Medical devices (Auckland, N.Z.)
Published: June 18, 2019
Most Promising Therapies in Interventional Cardiology.
Journal: Current cardiology reports
Published: March 15, 2019
Reduction of Cardiovascular Mortality and Ischemic Events in Acute Medically Ill Patients.
Journal: Circulation
Published: February 26, 2019
Association of Anemia with Venous Thromboembolism in Acutely Ill Hospitalized Patients: An APEX Trial Substudy.
Journal: The American journal of medicine
Published: March 16, 2018
Triple Antithrombotic Therapy for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.
Journal: Progress in cardiovascular diseases
Published: January 17, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026